Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Thyroid hormone receptors are essential for hair growth and wound healing.

ICG-enhanced NIR laser therapy may be a promising acne treatment with improvement and no side effects.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

The method accurately measures hair growth with minimal risk and is better than other techniques.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Combining corticosteroids and minoxidil can quickly regrow hair lost from radiation.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Fluorescent tattoos are a good way to mark the scalp for hair treatments because they're accurate, invisible in normal light, and have low risk.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Lrig1 could be a marker for advanced sebaceous carcinoma.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

A quick method effectively detects banned substances in urine.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.